논문KCI 등재
Correspondence to editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (6)
- Yu J, "Macrophage ATG16L1 : Potential candidate for metabolic dysfunction-associated steatohepatitis treatment : Editorial on"Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy"", Clin Mol Hepatol, 30, pp.721~723 (2024)
- Wang Q, "Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy", Clin Mol Hepatol, 30, pp.515~538 (2024)
- Ko MS, "Mitophagy deficiency increases NLRP3 to induce brown fat dysfunction in mice", Autophagy, 17, pp.1205~1221 (2021)
- Goldman S, "Autophagy and adipogenesis : implications in obesity and type II diabetes", Autophagy, 6, pp.179~181 (2010)
- Liu K, "Impaired macrophage autophagy increases the immune response in obese mice by promoting proinflammatory macrophage polarization", Autophagy, 11, pp.271~284 (2015)
- Liao X, "Macrophage autophagy plays a protective role in advanced atherosclerosis", Cell Metab, 15, pp.545~553 (2012)
관련 논문AI추천
Macrophage ATG16L1: Potential candidate for metabolic dysfunction-associated steatohepatitis treatment: Editorial on “Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy”Junjie Yu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagyHaoming Zhou, Jinren Zhou, Ling Lu, Qingfa Bu, Qi Wang, Yuan Liang, Yufeng Pan, Zibo Xu대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제3호Correspondence to editorial on “DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease”Amal Magdy, Hee-Jin Kim, Mirang Kim, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호PNPLA3 is one of the bridges between TM6SF2 E167K variant and MASLD: Correspondence to editorial on “TM6SF2 E167K variant decreases PNPLA3-mediated PUFA transfer to promote hepatic steatosis and injury in MASLD”Baokai Sun, Likun Zhuang대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”Mingkai Chen, Yuanbin Liu대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Reply to Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”Dae Won Jun, Seung Min Lee대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호
이 간행물의 다른 논문 (78건)
Congratulatory remarks김원pp. 2-2Preface김승업pp. 3-3PrefaceDae Won Junpp. 4-4Optimal cut-offs of vibration-controlled transient elastography and magnetic resonance elastography in diagnosing advanced liver fibrosis in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysisYoung Eun Chon, Han Ah Lee, Hee Yeon Kim, Young-Joo Jin, Jung Hwan Yu, Ji Won Han, Mi Na Kim, Jihyun An, Seung Up Kim, Miyoung Choi, Dae Won Junpp. 117-133Diagnostic accuracy of vibration-controlled transient elastography for staging liver fibrosis in autoimmune liver diseases: A systematic review and meta-analysisYoung Eun Chon, Miyoung Choi, Ji Won Han, 전대원, Mi Na Kim, Jung Hwan Yu, Young-Joo Jin, Hee Yeon Kim, Han Ah Lee, 김승업, Jihyun An, Gunho Kimpp. 134-146